The risk of cardiovascular diseases in diabetic patients and even in those with IGT are associated with insulin resistance, two-to threefold higher than that in control subjects [1] . The United Kingdom Prospective Diabetes Study (UKPDS) and other similar studies indicated that intensive control of blood glucose in diabetic patients prevents and slows the progression of microvascular complications, but has little effect on the prevention of macrovascular complications i. e. acute myocardial infarction (AMI) [2] . Excessive macrovascular diseases in diabetes have thus been considered to be due to insulin resistance and/or hyperinsulinaemia.
and compensatory hyperinsulinaemia with increased coronary events in diabetic patients is poorly understood. There are few publications about the direct atherogenic actions of insulin on the endothelium compared with those on vascular smooth muscle cells. The aim of this study was to elucidate whether high insulin directly affects neutrophil-endothelial cell adhesion and surface expression of endothelial adhesion molecules. We also examined what intracellular mechanisms are involved in these events. Methods. Studies of adhesion between neutrophils from healthy volunteers and human umbilical vein endothelial cells incubated in insulin-rich medium were carried out. Adhered neutrophils were quantified by measuring their myeloperoxidase activities and surface expression of endothelial adhesion molecules was examined using an enzyme immunoassay. Results. High insulin enhanced neutrophil-endothelial cell adhesion with an increase in the expression of intercellular adhesion molecule-1 but not E-selectin or P-selectin. Both phenomena were attenuated by pretreatment with protein kinase C inhibitors and a mitogen activated protein kinase inhibitor. Conclusions/interpretation. These results suggest that hyperinsulinaemia causes vascular injury by directly exacerbating neutrophil-endothelial cell adhesion through increasing endothelial expression of intercellular adhesion molecule-1 via activation of protein kinase and mitogen activated protein kinase pathways. aemia is an early and prominent event in atherosclerosis, so far there have been few reports about the direct atherogenic action of high insulin on the endothelium compared to vascular smooth muscle cells. We evaluated the direct atherogenic actions of high insulin on the endothelium, particularly the enhancement of neutrophil-endothelial cell adhesion and the involvement of endothelial adhesion molecule expression. We also examined the intracellular mechanisms involved in these events.
Materials and methods
This study was carried out in accordance with the Declaration of Helsinki as revised in 1996.
Cell culture. Human umbilical vein endothelial cells (HUVEC; Kurabo, Osaka, Japan) were cultured in collagen I-coated plates in CS-C medium (45 % DMEM, 45 % Ham's F12 medium, 10 % foetal bovine serum, 10 ng/ml acidic±fibroblast growth factor, 50 U/ml heparin, and 15 mmol/l HEPES; Cell Systems, Kirkland, Washington., USA) with antibiotic-antimicotic (Gibco BRL, Grand Island, N. Y., USA) at 37 C in a 100 % humidified atmosphere containing 5 % CO 2 .
Neutrophil isolation. Human neutrophilic polymorphonuclear leukocytes (PMN) were isolated from venous blood of healthy volunteers, who gave their informed consent, using standard dextran sedimentation and gradient separation on histopaque 1077 (Sigma, St. Louis, Mo., USA). This procedure yields a PMN population which is 98 % pure (acetic acid-crystal violet staining) and 95 to 98 % viable (trypan blue exclusion). No platelet contamination was seen in the isolated PMN examined using a microscope.
Neutrophil-endothelial cell adhesion assay. A neutrophil-endothelial cell adhesion assay was carried out [4] . Briefly, HU-VEC were cultured on 48-well plates, and incubated for 48 h with or without human regular insulin (Novolin R, Novo-Nordisk, Bagsvaard, Denmark). After treatment, medium was replaced with Hank's balanced salt solution (HBSS), and neutrophils (1 10 5 cells/well) were added and allowed to adhere for 30 min. After washing out non-adhered neutrophils, adhered neutrophils were quantified using a myeloperoxidase (MPO) assay. Neutrophil adhesion was expressed as the ratio of MPO activity of adhered neutrophils to that of the total neutrophils (1 10 5 cells).
Surface expression assay of endothelial adhesion molecules.
The surface expression of endothelial adhesion molecules (ICAM-1, P-selectin, E-selectin) was measured [4] . Briefly, after treatment of cells with or without insulin for 48 h in 24-well plates, cells were incubated with an anti-adhesion molecule antibody (primary antibody; diluted 1:100±250; Sigma) for 60 min, followed by incubation with horseradish peroxidase-conjugated goat anti-mouse IgG (diluted 1:2500±5000; Sigma) for 60 min in HBSS and phosphate-buffered saline containing 5 % foetal calf serum. Cells were then incubated for 60 min in the dark with 0.25 ml of 0.003 % H 2 O 2 plus 0.1 mg/ ml 3,3', 5,5'-tetramethylbenzidine as a substrate. The reaction was stopped by adding 75 ml of 8 NH 2 SO 4 , and the samples were transferred to 96-well plates which were read at 450 nm on a plate reader. 
Results
Effects of high insulin on PMN adhesion to HUVEC and surface expression of endothelial adhesion molecules. Insulin at a concentration of 100 mU/ml (0.609 nmol/l) increased both PMN adhesion and endothelial ICAM-1 expression within 48 h ( Fig. 1, 2) . However, endothelial expression of P-selectin and E-selectin was not affected by high insulin. Addition of an antibody specific for ICAM-1 (10 mg/ml) attenuated the enhanced-PMN adhesion to HUVEC mediated by the high insulin stimulation while neither an anti-P-selectin nor an anti-E-selectin antibody (10 mg/ml) affected the event (control: 6.9 0.3 %; high insulin: 11.5 0.1 %, p < 0.001 vs control; high insulin + anti-ICAM-1 antibody 8.3 0.3 %, p < 0.001 vs high insulin; high insulin + anti-P-selectin antibody 11.8 0.4 %; high insulin + anti-E-selectin antibody 11.2 0.3 %).
Effects of intracellular second messenger inhibitors on the high insulin-mediated PMN adhesion and ICAM-1 expression. We attempted to define the signal transduction pathways involved in the high insulin-mediated endothelial events. The enhanced neutrophil-endothelial cell adhesion caused by 100 mU/ml insulin for 48 h was attenuated by a classic PKC inhibitor, Gö6976 (10 nmol/l) and a broad PKC inhibitor, Gö6983 (0.1 mmol/l) (Fig. 1A) . In addition, we examined the participation of two insulin receptor-mediated tyrosine kinases, MAP kinase and PI-3 kinase, in the high insulin-mediated event and found that a MAP kinase inhibitor, PD98 059 (10 mmol/l) but not a PI-3 kinase inhibitor, wortmannin (10 nmol/l) attenuated the phenomenon (Fig. 1B) .
Furthermore, we found that the enhanced expression of endothelial ICAM-1 caused by 100 mU/ml insulin for 48 h was also inhibited by the same concentration of Gö6976 ( Fig. 2A), Gö6983 (Fig. 2B ) and PD98 059 (Fig. 2C ).
Discussion
We found evidence for the direct atherogenic actions of insulin which enhanced neutrophil-endothelial cell adhesion at a concentration of 100 mU/ml incubated for 48 h. The insulin concentration which we used, 100 mU/ml is thought to be around the physiological concentration present in the insulin-resistant condition because blood concentrations greater than 100 mU/ml can be found in insulin resistant subjects [5] . In addition, similar insulin concentrations around 100 mU/ml were used in other experiments [6] .
Because it has been reported that neutrophil-endothelial cell adhesion is modulated by several endothelial adhesion molecules, we hypothesized that the enhanced adhesion caused by high insulin was secondary to the induction of adhesion molecules on insulin-activated endothelial cells. We found that the enhanced PMN adhesion observed with 100 mU/ml insulin incubated for 48 h was associated with an increase in the expression of endothelial ICAM-1 but not E-selectin or P-selectin. This finding was strongly confirmed by the inhibitory effect of an anti-ICAM-1 antibody on the high insulin-enhanced PMN adhesion. Our results agree with a study [7] which showed that the surface expression of E-selectin rapidly increased after activation of HUVEC with tumour necrosis factor-alpha or interleukin-1 and then decreased to below detection values within 24 h, whereas ICAM-1 expression gradually increased, reached a plateau after 24 h, and remained constant for 3 days.
Next we investigated the intracellular signal transduction pathways which could be involved in the high insulin-mediated neutrophil-endothelial cell adhesion and endothelial ICAM-1 expression. We found that two distinct PKC inhibitors, Gö6976 and Gö6983 attenuated both, suggesting the involvement of this pathway. Little has been known about the correlation between the insulin actions and a PKC pathway, however the involvement of a PKC pathway in insulin-like growth factor-1 actions has been reported [8] .
Another report has indicated that insulin has two different actions considered to be either atherogenic through a MAP kinase pathway or anti-atherogenic through a PI-3 kinase pathway [9] . We therefore further evaluated the correlation between the insulin actions and these insulin receptor-mediated tyrosine kinases and found that both endothelial events medi-M. Okouchi et al.: High insulin and neutrophil-endothelial cell adhesion Fig. 1 (A, B) . Effects of intracellular second messenger inhibitors on the enhanced PMN adhesion to HUVEC mediated by high insulin. Cells were treated without (control) or with 100 mU/ml insulin for 48 h (insulin) in the presence or absence of a classic PKC inhibitor, 10 nmol/l Gö6976 (A), a broad PKC inhibitor, 0.1 mmol/l Gö6983 (A), a MAP kinase inhibitor, 10 mmol/l PD98 059 (B), and a PI-3 kinase inhibitor, 10 nmol/l wortomannin (B). Values are expressed as means SEM. *p < 0.01, **p < 0.001 compared to the respective control, #p < 0.01, ##p < 0.001 compared to the cells treated with high insulin alone Fig. 2 (A±C) . Effects of PKC and MAP kinase inhibitors on the enhanced surface expression of endothelial ICAM-1 mediated by high insulin. Cells were treated without (control) or with 100 mU/ml insulin for 48 h (insulin) in the presence or absence of a classic PKC inhibitor, 10 nmol/l Gö6976 (A), a broad PKC inhibitor, 0.1 mmol/l Gö6983 (B), and a MAP kinase inhibitor, 10 mmol/l PD98 059 (C). Values are expressed as means SEM. *p < 0.001 compared to the respective control, #p < 0.001 compared to the cells treated with high insulin alone A B A B C ated by high insulin were attenuated by pretreatment with a MAP kinase inhibitor, PD98 059 but not a PI 3-kinase inhibitor, wortmannin. These results are consistent with a previous report [10] , showing that MAP kinase activation is integral to the increase in endothelial ICAM-1.
In conclusion, our study casts a new light on the direct atherogenic actions of insulin on the endothelium which results from enhanced neutrophil-endothelial cell adhesion through an increase in the surface expression of endothelial ICAM-1. These phenomena were likely to be mediated by the activation of PKC and MAP kinase pathways. The evidence on the intracellular signal transduction pathways involved in the events mediated by high insulin should facilitate the development of better pharmacologic agents to prevent vascular complications in patients with diabetes and IGT, particularly those with insulin resistance.
